EPISODE · Oct 17, 2024 · 16 MIN
Inavolisib
from OncoPharm · host John Bossaer
A new PIK3Ca inhibitor is approved for breast cancer.
Embed this episode
Ready to play
Inavolisib
0:00
16:42
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of OncoPharm?
This episode is 16 minutes long.
When was this OncoPharm episode published?
This episode was published on October 17, 2024.
Can I download this OncoPharm episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!